Literature DB >> 32953478

Uniportal video-assisted thoracic surgery for the treatment of lung cancer: a consensus report from Chinese Society for Thoracic and Cardiovascular Surgery (CSTCVS) and Chinese Association of Thoracic Surgeons (CATS).

Dingpei Han1, Yuqin Cao1, Han Wu1, Haifeng Wang2, Lei Jiang2, Deping Zhao2, Feng Yao3, Shuben Li4, Chong Zhang5, Bin Zheng6, Junqiang Fan7, Yongde Liao8, Bin Qiu9, Fengwei Tan9, Chun Chen6, Yuming Zhu2, Shugeng Gao9, Hecheng Li1.   

Abstract

Uniportal video-assisted thoracoscopic surgery (UniVATS) has been widely adopted in China, where several ultra-high volume thoracic surgical and training centers are located. The objective of this consensus from Chinese experts was to summarize the current application and give reference for the future development of UniVATS in the treatment of lung cancer. A panel of 41 experts from 21 Chinese hospitals was invited to join this project. The Delphi method was used in this consensus consisting of two rounds of voting. The questionnaire was based on the current clinical evidence. Forty (97.6%) experts completed the 2 rounds of questionnaires. The experts' experience was relatively similar. We defined the UniVATS as monitor-dependent surgery, no use of rib-spreading and single incision less than 4 cm. Tumor with stage of T1-T3 and N0-N2 is considered amenable to UniVATS. Other consensus was reached on several points outlining the safety and feasibility, surgical skills, learning curve, short-term and long-term outcomes for lung cancer, and current application of subxiphoid and nonintubated UniVATS approach. This consensus statement represents a collective agreement among Chinese experts to suggest that UniVATS is an effective alternative to multi-portal approach, although high-level evidence is expected in the future. Some agreements can be referred in the training of young surgeons. 2020 Translational Lung Cancer Research. All rights reserved.

Entities:  

Keywords:  Consensus; lung cancer; uniportal video-assisted thoracoscopic surgery (UniVATS)

Year:  2020        PMID: 32953478      PMCID: PMC7481589          DOI: 10.21037/tlcr-20-576

Source DB:  PubMed          Journal:  Transl Lung Cancer Res        ISSN: 2218-6751


Introduction

It has been more than a decade since uniportal video-assisted thoracoscopic surgery (UniVATS) was applied in thoracic surgery (1). Compared with the multi-portal video-assisted thoracoscopic surgery (VATS), UniVATS was related to less invasion and a vertical vision similar to open surgery (2). The first UniVATS lung cancer resection was described in 2010 (3). With the development of surgical skills and instruments, many complex thoracic procedures were reported to be performed by UniVATS approach (4-6). Nowadays, UniVATS has been widely accepted and adopted in China but is less prevalent in Western countries, lack of high-quality evidence might be one of the reasons (7). In 2019, the Uniportal VATS Interest Group (UVIG) of the European Society of Thoracic Surgeons (ESTS) has published a consensus report on UniVATS for lobectomy (8), aiming to define and standardize the procedures, to optimize the indications and perioperative management, and to provide advice for future training. However, the largest quantity of UniVATS is performed in China, where several ultra-high volume thoracic surgical centers are located (9). Therefore, a consensus from Chinese experts will have a significance of reference in summarizing the current application of UniVATS in lung cancer. In this consensus, not only lobectomy, but also segmentectomy, subxiphoid and nonintubated approach were included. The recommendations from the experts will be helpful for the future development of UniVATS.

Methods

The Delphi method was implemented in the development of this consensus, which was initiated by Chinese Society for Thoracic and Cardiovascular Surgery (CSTCVS) and Chinese Association of Thoracic Surgeons (CATS). The characteristic and value of Delphi method in the field of health have been previously described (8). A total of 41 members from 21 Chinese hospitals were invited to participate in the 2 rounds of voting through questionnaire. All the experts possessed rich experience in both open and minimally invasive thoracic surgery, representing the top-volume surgical training and academic centers in China, most of them were the department directors or enjoyed the high reputation in field of thoracic surgery in China. The panel of the experts was identified by the corresponding authors of this manuscript. The questionnaire was based on the current clinical evidence, including single choice, multiple choice, and survey questions. Each of the 2 rounds of voting was made through an online platform of questionnaire survey, evaluation and voting. The applet of the online platform was individually sent to the experts by WeChat (a social software) and was set to be opened only by the experts themselves. The first round of questionnaire was sent on 19th June 2019 and was valid for a week. Anonymous results of the first round was attached to the second round of questionnaire sent on 28th June 2019, which was also valid for a week. A seminar on the consensus was held on 19th August 2019 to reveal the anonymous results of the second round. The results of the second round formed the basis of this consensus. The statistical analysis was finished by the online platform. Consensus was defined a priori as more than 50% agreement among the experts. The clinical practice was considered as “recommended (grade II)” if 50–74% of the experts reached an agreement and “highly recommended (grade I)” if 75% or more of the panel reached an agreement.

Results

A total of 40 (97.6%) experts completed the 2 rounds of questionnaires. A summary of their institutions’ case volume and time period of conducting UniVATS for lung cancer is shown in . The experts’ experience was relatively similar.
Figure 1

Surgical experience among the expert's institutions. (A) Distribution of surgical volume of UniVATS for lung cancer per year among the participating experts’ institutions; (B) distribution of time period of UniVATS for lung cancer among the participating experts’ institutions. UniVATS, uniportal video-assisted thoracoscopic surgery.

Surgical experience among the expert's institutions. (A) Distribution of surgical volume of UniVATS for lung cancer per year among the participating experts’ institutions; (B) distribution of time period of UniVATS for lung cancer among the participating experts’ institutions. UniVATS, uniportal video-assisted thoracoscopic surgery. The definition of UniVATS is shown in . Fifty-two point five experts make a 4-cm incision (grade II); 95% experts use an incision retractor (grade I); all the experts stand on the ventral side of the patient with their assistants on the opposite side (62.5%, grade II); 10-mm camera is commonly used (97.5%, grade I) and fixed on the dorsal side of the incision (90%, grade I); after surgery, only one chest tube (95%, grade I) less than or equal 24-Fr (75%, grade I) is recommended to be placed in the same intercostal space through the incision (97.3%, grade I) and fixed on the dorsal side of the incision (75%, grade I); no other inserted catheter such as pig-tail catheter is recommended.
Table 1

Definition of UniVATS for lung resection

QuestionN (%)
What would be the size of incision?
   2 cm0
   3 cm18 (45.0)
   4 cm21 (52.5)
   5 cm1 (2.5)
   >5 cm0
Do you use incision retractor?
   Yes38 (95.0)
   No2 (5.0)
Which side do you fix the camera on?
   Dorsal side of the incision36 (90.0)
   Ventral side of the incision2 (5.0)
   No fix2 (5.0)
What type of camera do you use?
   5 mm1 (2.5)
   10 mm39 (97.5)
Which side do you stand?
   Dorsal side of the patient0
   Ventral side of the patient40 (100.0)
Which side do your assistant stand?
   Same side13 (32.5)
   Opposite side25 (62.5)
   As appropriate2 (5.0)
How many chest tubes placed after surgery?
   138 (95.0)
   22 (5.0)
What the size of chest tube placed after surgery?
   16 Fr2 (5.0)
   20 Fr15 (37.5)
   24 Fr13 (32.5)
   28 Fr10 (25.0)
How do you place the chest tube?
   The same intercostal space through the incision39 (97.3)
   Another intercostal space through the incision1 (2.5)
   Make another incision0
Which side do you fix the chest tube?
   Dorsal side of the incision30 (75.0)
   Ventral side of the incision4 (10.0)
   Middle of the incision6 (15.0)
Do you use another inserted catheter (pig-tail catheter)?
   Yes20 (50.0)
   No20 (50.0)

UniVATS, uniportal video-assisted thoracoscopic surgery.

UniVATS, uniportal video-assisted thoracoscopic surgery. As demonstrated in , incision at 5th intercostal space is recommended for UniVATS lobectomy of right middle lobe (RML) (55%, grade II), right lower lobe (RLL) (75%, grade I), left upper lobe (LUL) (65%, grade II), and left lower lobe (LLL) (72.5%, grade II); for UniVATS segmentectomy, incision at 5th intercostal space is recommended in RML (57.5%, grade II), RLL (87.5%, grade I), LUL (60%, grade II), and LLL (87.5%, grade I), while incision at 4th intercostal space is recommended in right upper lobe (RUL) (70%, grade II). As shown in , there is a strong recommendation of UniVATS at anterior-middle axillary line (≥80% for all lobes, grade I).
Table 2

Site (intercostal space) of the incision for UniVATS

Location3rd4th5th6th7th
Lobectomy, n (%)
   RUL020 (50.0)20 (50.0)00
   RML2 (5.0)14 (35.0)22 (55.0)2 (5.0)0
   RLL010 (25.0)30 (75.0)00
   LUL014 (35.0)26 (65.0)00
   LLL010 (25.0)29 (72.5)1 (2.5)0
Segmentectomy, n (%)
   RUL028 (70.0)12 (30.0)00
   RML1 (2.5)14 (35.0)23 (57.5)2 (5.0)0
   RLL05 (12.5)35 (87.5)00
   LUL016 (40.0)24 (60.0)00
   LLL05 (12.5)35 (87.5)00

RUL, right upper lobe; RML, right middle lobe; RLL, right lower lobe; LUL, left upper lobe; LLL, left lower lobe; UniVATS, uniportal video-assisted thoracoscopic surgery.

Table 3

Placement of incision for UniVATS

LocationAnterior axillary lineAnterior-middle axillary lineMiddle axillary lineMiddle-posterior axillary linePosterior axillary line
RUL, n (%)2 (5.0)32 (80.0)3 (7.5)3 (7.5)0
RML, n (%)1 (2.5)33 (82.5)3 (7.5)3 (7.5)0
RLL, n (%)1 (2.5)34 (85.0)2 (5.0)3 (7.5)0
LUL, n (%)034 (85.0)3 (7.5)3 (7.5)0
LLL, n (%)035 (87.5)2 (5.0)3 (7.5)0

RUL, right upper lobe; RML, right middle lobe; RLL, right lower lobe; LUL, left upper lobe; LLL, left lower lobe; UniVATS, uniportal video-assisted thoracoscopic surgery.

RUL, right upper lobe; RML, right middle lobe; RLL, right lower lobe; LUL, left upper lobe; LLL, left lower lobe; UniVATS, uniportal video-assisted thoracoscopic surgery. RUL, right upper lobe; RML, right middle lobe; RLL, right lower lobe; LUL, left upper lobe; LLL, left lower lobe; UniVATS, uniportal video-assisted thoracoscopic surgery. A summary of experts’ opinions regarding the eligibility of UniVATS for lung cancer is presented in . Tumor with stage of T1–T3 (60%, grade II) and N0–N2 (77.5%, grade I) is considered amenable to UniVATS; preoperative chemotherapy is not a contraindication (85%, grade I), while previous thoracic surgery or pleurisy (57.5%, grade II), tumor invading the hilar (90%, grade I), and invasion of chest wall, phrenic nerve or pericardium (85%, grade I) are considered as relative contraindications; regarding the indication of sleeve resection, only bronchus sleeve resection is recommended to be performed by UniVATS (62.5%, grade II); according to this consensus, UniVATS is suitable for pneumonectomy (92.5%, grade I) and is deemed feasible and safe for segmentectomy (97.5%, grade I).
Table 4

Eligibility of UniVATS for lung cancer

QuestionN (%)
T stage
   T10
   T1, T216 (40.0)
   T1, T2, T3 (≤7 cm)24 (60.0)
N stage
   N00
   N0, N19 (22.5)
   N0, N1, N231 (77.5)
Preoperative chemotherapy is
   Absolute contraindication0
   Relative contraindication6 (15.0)
   Not a contraindication34 (85.0)
Preoperative radiotherapy is
   Absolute contraindication10 (25.0)
   Relative contraindication15 (37.5)
   Not a contraindication15 (37.5)
Previous thoracic surgery/pleurisy is
   Absolute contraindication0
   Relative contraindication23 (57.5)
   Not a contraindication17 (42.5)
Tumor invading the hilar structure is
   Absolute contraindication1 (2.5)
   Relative contraindication36 (90.0)
   Not a contraindication3 (7.5)
Tumor invading chest wall, phrenic nerve or pericardium is
   Absolute contraindication3 (7.5)
   Relative contraindication34 (85.0)
   Not a contraindication3 (7.5)
Indication of sleeve resection
   Bronchus sleeve and sleeve angioplasty13 (32.5)
   Bronchus sleeve25 (62.5)
   Sleeve angioplasty0
   Not for all2 (5.0)
Whether UniVATS is suitable for pneumonectomy?
   Yes37 (92.5)
   No3 (7.5)
UniVATS segmentectomy is safety and feasible
   Agree39 (97.5)
   Neither agree nor disagree1 (2.5)
   Disagree0

UniVATS, uniportal video-assisted thoracoscopic surgery.

UniVATS, uniportal video-assisted thoracoscopic surgery. A summary of safety and feasibility of UniVATS for lung cancer is shown in . Calcified lymph nodes (70%, grade II), extensive pleural adhesions (65%, grade II), technical difficulties (70%, grade II), and massive hemorrhage (95%, grade I) are the main reasons for auxiliary operating ports, while calcified lymph nodes (60%, grade II) and massive hemorrhage (92.5%, grade I) are the dominant reasons for conversion; most experienced experts would try to deal with pulmonary vascular branch bleeding (97.5%, grade I) or tracheobronchial injury (92.5%, grade I) by UniVATS, and they agree on the absence of difference between UniVATS and multi-portal VATS in terms of mortality and intraoperative adverse events according to the current literature (92.5%, grade I).
Table 5

The safety and feasibility of UniVATS for lung cancer

QuestionN (%)
Under which situations would you add another port?
   Extensive pleural adhesions26 (65.0)
   Calcified lymph nodes28 (70.0)
   Absence of fissure3 (7.5)
   Poor lung deflation12 (30.0)
   Involvement of nerves or pericardium15 (37.5)
   Poor assistant cooperation20 (50.0)
   Other technical difficulties28 (70.0)
   Massive hemorrhage38 (95.0)
   None of above0
Under which situations would you convert to open?
   Extensive pleural adhesions10 (25.0)
   Calcified lymph nodes24 (60.0)
   Absence of fissure1 (2.5)
   Poor lung deflation5 (12.5)
   Involvement of nerves or pericardium13 (32.5)
   Poor assistant cooperation8 (20.0)
   Other technical difficulties21 (52.5)
   Massive hemorrhage37 (92.5)
   None of above0
Under which situations would you try to deal with by UniVATS?
   Pulmonary vascular trunk bleeding22 (55.0)
   Pulmonary vascular branch bleeding39 (97.5)
   Tracheobronchial injury37 (92.5)
Only surgeons with rich experience can try to deal with massive hemorrhage by UniVATS
   Agree38 (95.0)
   Neither agree nor disagree2 (5.0)
   Disagree0
No differences between UniVATS and multi-portal VATS in terms of mortality, incidence of intraoperative adverse events
   Agree37 (92.5)
   Neither agree nor disagree3 (7.5)
   Disagree0

UniVATS, uniportal video-assisted thoracoscopic surgery.

UniVATS, uniportal video-assisted thoracoscopic surgery. As shown in , most experts need 2 assistants (60%, grade II) with higher capability (97.5%, grade I); both the site of incision (100%, grade I) and the capability of assistant (100%, grade I) can influence the processing fluency of UniVATS; systematic lymph nodes dissection is recommended for lobectomy (92.5%, grade I) while systematic lymph nodes sampling is recommended for segmentectomy (75%, grade I) in UniVATS after lung resection (85%, grade I); concerning the current evidence, the experts agree that there is no difference between UniVATS and multi-portal approach in the quantity of lymph nodes dissection (92.5%, grade I); paravertebral intercostal nerve block (62.5%, grade II) is not recommended after UniVATS procedure.
Table 6

Surgical skills of UniVATS for lung cancer

QuestionN (%)
How many assistants do you need?
   116 (40.0)
   224 (60.0)
   30
How is the capability requirement for assistant?
   UniVATS requires higher capability39 (97.5)
   Multi-portal VATS requires higher capability1 (2.5)
   No difference0
The site of incision is an influence on the procedure
   Yes40 (100.0)
   No0
The capability of assistant is an influence on the procedure
   Yes40 (100.0)
   No0
Which is the proper management of lymph nodes in lobectomy?
   Systematic lymph nodes dissection37 (92.5)
   Lobe-specific lymph nodes dissection2 (5.0)
   Systematic lymph nodes sampling1 (2.5)
   Lobe-specific sampling0
   Random/no sampling0
Which is the proper management of lymph nodes in segmentectomy?
   Systematic lymph nodes dissection1 (2.5)
   Lobe-specific lymph nodes dissection5 (12.5)
   Systematic lymph nodes sampling30 (75.0)
   Lobe-specific sampling4 (10.0)
   Random/no sampling0
Which is the proper management of lymph nodes?
   Lung resection before lymph nodes dissection34 (85.0)
   Lymph nodes dissection before lung resection6 (15.0)
The quantity of lymph nodes harvested is?
   More by UniVATS0
   More by multi-portal approach2 (5.0)
   No difference between the two approaches37 (92.5)
   Not sure1 (2.5)
Do you perform paravertebral intercostal nerve block after surgery?
   Yes15 (37.5)
   No25 (62.5)

UniVATS, uniportal video-assisted thoracoscopic surgery.

UniVATS, uniportal video-assisted thoracoscopic surgery. Regarding the learning curve of UniVATS (), 30 cases are deemed the cut-off point both for lobectomy (70%, grade II) and segmentectomy (72.5%, grade II); operative time (87.5%, grade I) and perioperative complications (87.5%, grade I) are two recommended evaluation indices of learning curve for UniVATS. Surgeons should perform at least 50 cases annually to maintain uniportal operative skills (60%, grade II), and some training programs such as video training (82.5%, grade I) and long-term advanced study (82.5%, grade I) are highly recommended for young surgeons; in addition, the experts’ scores evaluating difficulty in lobectomy are ranked as follows (from complex to simple): LUL, RML, RLL, RUL, and LLL.
Table 7

The learning curve of UniVATS for lung cancer

QuestionN (%)
How many cases are required for the learning curve of lobectomy?
   About 3028 (70.0)
   About 5012 (30.0)
   About 700
   About 1000
How many cases are required for the learning curve of segmentectomy?
   About 3029 (72.5)
   About 5010 (25.0)
   About 700
   About 1001 (2.5)
What do you think about the learning curve?
   Uniportal approach is shorter2 (5.0)
   Multi-portal approach is shorter13 (32.5)
   No difference between the two approaches25 (62.5)
   Not sure0
Operative time is an evaluation index of learning curve
   Agree35 (87.5)
   Neither agree nor disagree5 (12.5)
   Disagree0
Perioperative complication is an evaluation index of learning curve
   Agree35 (87.5)
   Neither agree nor disagree5 (12.5)
   Disagree0
The experience of thoracotomy or multi-portal approach would affect the learning curve in young surgeons
   Agree19 (47.5)
   Neither agree nor disagree15 (37.5)
   Disagree6 (15.0)
The rank of lobectomy according to the difficulty (score)
   Left upper lobe4.48
   Right middle lobe3.55
   Right lower lobe2.35
   Right upper lobe2.30
   Left lower lobe2.28
How many cases are required for a surgeon to maintain the skills?
   About 255 (12.5)
   About 5024 (60.0)
   About 750
   About 10011 (27.5)
Which way of training do you recommend to young surgeon?
   Self-determination training24 (60.0)
   Video training33 (82.5)
   Consultation of experts15 (37.5)
   Animal experiment21 (52.5)
   Simulator25 (62.5)
   Webcast learning27 (67.5)
   Long-term advanced study33 (82.5)

UniVATS, uniportal video-assisted thoracoscopic surgery.

UniVATS, uniportal video-assisted thoracoscopic surgery. Regarding the short-term and long-term outcomes of UniVATS for lung cancer (), the experts reach an agreement on the absence of significant difference in postoperative drainage duration and length of stay (87.5%, grade I), overall complications and pulmonary complications (90%, grade I), and overall survival and disease free survival (90%, grade I) between UniVATS and multi-portal approach according to the current evidence; UniVATS shows a lower postoperative pain score (52.5%, grade II), a better emotional and functional status and a higher quality of life (62.5%, grade II) than multi-portal approach.
Table 8

Outcomes of UniVATS for lung cancer & other UniVATS approaches

QuestionN (%)
There is no significant difference in postoperative drainage duration and length of stay between UniVATS and multi-portal approach
   Agree35 (87.5)
   Neither agree nor disagree0
   Disagree5 (12.5)
Postoperative pain score in UniVATS is lower than in multi-portal approach (lower is better)0
   Agree21 (52.5)
   Neither agree nor disagree2 (5.0)
   Disagree17 (42.5)
UniVATS shows a better emotional and functional status and a higher quality of life than multi-portal approach
   Agree25 (62.5)
   Neither agree nor disagree3 (7.5)
   Disagree12 (30.0)
There is no significant difference in overall complications and pulmonary complications between UniVATS and multi-portal approach
   Agree36 (90.0)
   Neither agree nor disagree0
   Disagree4 (10.0)
UniVATS and multi-portal approach show no difference in survival rate as the treatment of early stage lung cancer
   Agree36 (90.0)
   Neither agree nor disagree4 (10.0)
   Disagree0
Subxiphoid UniVATS can reduce intercostal nerve injury and paina
   Agree10 (90.9)
   Neither agree nor disagree1 (9.1)
   Disagree0
Subxiphoid UniVATS is not recommended for complex procedurea
   Agree9 (81.8)
   Neither agree nor disagree2 (18.2)
   Disagree0
Nonintubated UniVATS can only be applied on condition of experienced medical team and rigorous selection of patients
   Agree32 (80.0)
   Neither agree nor disagree6 (15.0)
   Disagree2 (5.0)

a, eleven experts finished this question. UniVATS, uniportal video-assisted thoracoscopic surgery.

a, eleven experts finished this question. UniVATS, uniportal video-assisted thoracoscopic surgery. Base on the current literature, as shown in , the experts agree that subxiphoid UniVATS can reduce intercostal nerve injury and postoperative pain (90.9%, grade I), but is not recommended for complex procedure (81.8%, grade I); nonintubated UniVATS can be applied only on the condition of experienced medical team and rigorous selection of patients (80%, grade I). Other survey results are listed in . The experts suggest conducting randomized controlled trials about UniVATS to obtain high-level evidence (95%, grade I); the experts agree that UniVATS has benefited from the improvement of surgical instruments (92.5%, grade I) and serves as a promising direction of minimally invasive thoracic surgery (80%, grade I) and an effective part of enhance recovery after surgery for lung cancer (77.5%, grade II).
Table 9

Other survey

QuestionN (%)
The progress of UniVATS had benefited from the improvement of surgical instruments
   Agree37 (92.5)
   Neither agree nor disagree2 (5.0)
   Disagree1 (2.5)
UniVATS would be a development direction of minimally invasive thoracic surgery
   Agree32 (80.0)
   Neither agree nor disagree8 (20.0)
   Disagree0
Is it necessary to conduct a randomized controlled trial about UniVATS?
   Yes38 (95.0)
   No2 (5.0)
UniVATS is an effective part of enhance recovery after surgery for lung cancer
   Agree31 (77.5)
   Neither agree nor disagree8 (20.0)
   Disagree1 (2.5)

UniVATS, uniportal video-assisted thoracoscopic surgery.

UniVATS, uniportal video-assisted thoracoscopic surgery.

Discussion

Definition of UniVATS for lung resection

According to the consensus of the experts, we defined the UniVATS as “monitor-dependent surgery, no use of rib-spreading and single incision less than 4 cm”. Most experts agreed that the maximum size of incision should be less than 4 cm. Considering the fact that 97.5% of the experts used 10-mm camera, incision less than 3 cm might be gradually adopted owing to the popularization of slim camera and instruments (10,11). An anterior-middle axillary incision at 5th intercostal space was recommended by most of the experts for both lobectomy and segmentectomy, there were also reports on different locations of incision such as subaxillary, transcervical, and posterior axillary incision (12-14). Moreover, in order to prevent adverse events such as air or fluid leakage and impaired reconstruction of muscular layer, some surgeons proposed feasible methods for chest tube placement and incision closing (15,16). these attempts accompanied by different advantage or disadvantages reflected the effort made by surgeons to improving the procedure of UniVATS.

Eligibility of UniVATS for lung cancer

According to the results, UniVATS lung resection was recommended for tumor stage T1–T3 and N0–N2. It was usually believed that tissue adhesions and increased vascular fragility after neoadjuvant chemotherapy could increase the risk of surgery, but some recent studies suggested that preoperative chemotherapy had no effects on operative time, intraoperative complications, and lymph nodes dissection (17,18). So as showed in this consensus, preoperative chemotherapy was no longer a contraindication to UniVATS for lung resection. However, no consensus was reached on preoperative radiotherapy due to lack of relevant evidence. With the development of endoscopic instruments and surgical skills, experienced surgeons could perform complex operations by multi-portal VATS including sleeve resection and pneumonectomy with similar results compared to open surgery (19-21). According to this consensus, UniVATS was also suitable for bronchus sleeve resection and pneumonectomy (22-28). However, as case report and surgical techniques dominated the types of publication, the feasibility and safety of UniVATS on sleeve resection and pneumonectomy should be verified by future studies. UniVATS shared the same indications with multi-portal VATS for segmentectomy to treat lung cancer. Recent studies suggested that UniVATS segmentectomy was associated with less blood loss, shorter operative time and faster recovery compared with multi-portal VATS (4,29,30). Based on the current evidence, the experts agreed that UniVATS was feasible and safe for segmentectomy. The key procedures of UniVATS segmentectomy included location of nodules, selection and placement of instruments, and identification of intersegmental planes. Novel techniques such as three-dimensional reconstruction, magnetic navigation, and fluorochrome staining would facilitate the operation in both UniVATS and multi-portal VATS approach (31,32).

Safety and feasibility of UniVATS for lung cancer

According to the consensus, calcified lymph was a key point of UniVATS procedures, calcified nodes fused to the hilum, fissure and bronchus might lead to an accident during the procedure. It was reported that 41% of conversions in VATS lobectomy were due to hilar calcified nodes, which was the leading cause of intraoperative bleeding (33). Early studies suggested that the risk of intraoperative bleeding in VATS was higher than that in thoracotomy, especially in the initial stage of learning curve (34). However, a recent study with a large sample size revealed no difference in intraoperative complication rate between VATS and thoracotomy (1.57% vs. 1.44%, P=1.0) (35). Just like during the procedures of multi-portal VATS, the successful management of intraoperative complications by UniVATS was also related to the severity of complication, surgeons’ experience, surgical instruments, and the cooperation of assistants (36). An experienced team could try to deal with severe hemorrhage by UniVATS (37), while doctors in the learning stage needed to be familiar with anatomy, keep calm, and prepare for timely conversion to thoracotomy (38). So, agreement was reached by the experts that experienced surgeons could try to deal with intraoperative complications such as severe hemorrhage, vascular branch bleeding or tracheobronchial injury by UniVATS. Some experienced surgeons have shared their surgical skills to deal with calcified lymph nodes (39), which was no longer considered as a contraindication to both multi-portal VATS and UniVATS. Some retrospective studies on UniVATS have reported the mortality, the rate of conversion, and the intraoperative complication rate as 3.3% (40), 4.6%, and 5.6% (41), respectively. A retrospective literature review (40) implied no difference between uniportal and multi-portal VATS in operation time and intraoperative blood loss. Based on the current evidence, the experts agreed that there was no difference between uniportal and multi-portal approach in terms of intraoperative adverse events, rate of conversion to thoracotomy, and mortality.

Surgical techniques of UniVATS for lung cancer

UniVATS usually required one or two assistants, but it was more technically demanding for assistants than traditional thoracoscopy. In case of only one assistant available, the proficiency of the assistant would have a great impact on the procedure of UniVATS, a successful UniVATS is dependent on the tacit cooperation of the surgeon and the assistant, especially in emergency conditions (42). In addition, the location of incision would also greatly impact the procedure of UniVATS according the experts’ opinions. As mentioned in the results, systematic lymph node dissection was recommended for UniVATS lobectomy while systematic lymph node sampling was recommended for UniVATS segmentectomy. Regarding the number of lymph nodes dissection, evidence have showed controversial results between multi-portal VATS and open surgery (43,44). The similar situation was presented between UniVATS and multi-portal VATS, some reports indicated no difference between uniportal and multi-portal VATS, but some others suggested that uniportal approach yielded more lymph nodes than multi-portal approach did (40). Although the experts in this consensus agreed that there was no difference between UniVATS and multi-portal approach in the quantity of lymph nodes dissection, the conclusion should be verified by future high-level evidence. In order to optimize the surgical procedure, many surgeons have implemented some exploratory techniques of lymph node dissection in UniVATS as followed: Lateral prone position was used to improve the efficiency of mediastinal lymph node dissection (45); non-grasping technology was considered to reduce the interference of surgical instruments and to clarify the surgical field: the suction could not only eliminate the smoke produced by electric hook or ultrasonic knife and the bleeding or exudate caused by separating procedure, but also had the role of blunt dissection and traction without clamping lymph nodes, which could minimize the fracture of lymph nodes and consequent bleeding (46). In addition, reduced operation time and intraoperative blood loss were reported in a modular pattern of UniVATS lymphadenectomy, in which the lymph nodes were resected in the following order: (I) right lung: dissection of group 7, 8, 9, 10 lymph nodes, followed by lung resection and finally the dissection of upper mediastinal lymph nodes; (II) left lung: dissection of group 8, 9, 7, 10, 5, 4L, 6 lymph nodes, and then lung resection (47). Although the surgical techniques mentioned above were mostly based on the clinical experience of each center and lacked high quality evidence, the experts’ consensus might provide young surgeons with some references.

Learning curve of UniVATS for lung cancer

Learning curve was generated to evaluate the surgical proficiency of surgeons by comparing the changes of perioperative indices, which reflected not only the competence of surgeons, but also the complexity of the procedure. According to the current evidence, the cut-off value in the learning curve of UniVATS for lobectomy varied from 25 to 40 cases (48-51), and the consensus gave a recommendation of 30 cases. The cut-off point in the learning curve of UniVATS segmentectomy was reported as 33 cases by a sole study (52) and recommended as 30 cases by the experts. Similarly, the cut-off point was 27 cases in the learning curve of multi-portal VATS for lung resection (53). So, this consensus suggested that there was no difference between uniportal and multi-portal VATS in terms of learning curve. Operation time was considered as an important evaluation index of learning curve in this consensus, it was significantly reduced after finishing the learning curve in both lobectomy and segmentectomy according to the above studies. In addition, postoperative hospital stay, drainage duration, intraoperative bleeding, conversion rate, operative mortality, and complication rate were also reported as indicators in the learning curve for UniVATS (48). According to this consensus, the experts agreed that postoperative complication rate was another ideal evaluation index of learning curve for UniVATS. The basic skills of young surgeons were usually considered as an influence on the learning curve. However, the experts did not reach an agreement that the experience of thoracotomy or multi-portal VATS would affect the learning curve of UniVATS. For young doctors, video training, long-term advanced study, self-determination training, training on simulator, and webcast learning were recommended by the experts. In addition, according to the experts’ scores, the rank of difficulty in UniVATS lobectomy was as LUL, RML, RLL, RUL, and LLL (from complex to simple), serving as a reference for young trainees.

Short-term and long-term outcomes of UniVATS for lung cancer

According to a systematic review of published evidence (40), most studies showed no difference in length of stay and drainage duration after surgery between UniVATS lobectomy and multi-portal approach. According to a meta-analysis involving 4,635 participants from 39 studies, UniVATS held advantages over conventional VATS in postoperative pain, length of stay, and duration of chest drain (54). Although the current evidence showed disputed results, the experts agreed that there was no significant difference in postoperative drainage duration and length of stay between UniVATS and multi-portal VATS, but UniVATS reported lower pain scores after surgery. In terms of quality of life, retrospective studies supported that the small incision of UniVATS caused less hyperalgesia, numbness and allodynia after lobectomy than the multi-portal approach, thus leading to a higher satisfaction with incision (55). The European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30) and the supplemental questionnaire QLQ-LC13 were adopted in another study where UniVATS indicated advantages over multi-portal VATS in functional status (physical function, role function, emotional function, and social function) and overall health condition at 2, 4 and 8 weeks after surgery (56). The panel of experts agreed that patients undergoing UniVATS showed better emotional and functional status after surgery and had a higher quality of life than those undergoing multi-portal VATS. Complication rates after UniVATS ranged from 3% to 40% in different publications (40). Such a discrepancy was associated with the sample size and type of complications as well. Studies with a larger sample size (>100) reported 4–14% postoperative complications (41,57-62), among which prolonged air leak, pulmonary infection, and atelectasis were the leading ones. A meta-analysis with the highest quality of evidence reported no significant difference in postoperative complication rates between UniVATS and multi-incisional VATS [odds ratio (OR) =0.80, 95% confidence interval (CI): 0.59–1.08, P=0.15] (54). Several published comparative studies included pulmonary complications reported that incidence rates were reported as 5.1–17.8% after UniVATS and 4–20% after multi-portal VATS (55,62-66), indicating no significant difference between two approaches. The experts reached an agreement on the absence of difference in the incidence of overall complications and pulmonary complications between UniVATS and multi-portal VATS. Regarding long-term outcomes, a retrospective study reported a 2-year survival rate of 96% for stage I lung cancer and 83% for stage II lung cancer after UniVATS major lung resections (60). According to another observational study, the 3-year overall survival rate of stage IA and IB lung cancer was 93.2%, 93.7%, and 87.3% in single-port, two-port, and three-port VATS group, respectively. Statistical difference was neither observed in overall survival nor recurrence-free survival (61). In a recent study, the 5-year overall survival rate was 80.1% for stage I lung cancer treated by UniVATS lobectomy, the 4-year progression-free survival rate of UniVATS segmentectomy was 94.1% (67). Agreement was reached by the experts that UniVATS and multi-portal VATS showed no difference in survival rate as the treatment of early stage lung cancer.

Subxiphoid UniVATS approach for lung cancer

This innovative approach was first applied in the thymectomy in 2012 (68) and in 2014 was reported the first subxiphoid UniVATS lobectomy (69). So far, UniVATS via subxiphoid approach has been applied in segmentectomy (70), synchronous bilateral segmentectomy (71), hilar calcified lymph nodes resection (72), and other complex surgeries. Regarding the safety, in a case series of 172 subxiphoid lobectomies, the conversion rate was 4.1% to open surgery and 2.9% to multi-portal approach, mortality was 0% and morbidity was 10.5% (73). Compared with conventional intercostal incision, the advantage of subxiphoid approach lied in reducing damage to intercostal nerve and postoperative pain. It was reported in a retrospective study that the pain scores from the first day after surgery to discharge were significantly lower in the group of subxiphoid UniVATS than in the group of intercostal UniVATS (74). However, the limited number of studies were mostly published by a same center, thus appealing for further evidence for the safety and feasibility of UniVATS via subxiphoid approach. There was no strong agreement in the safety and feasibility of subxiphoid UniVATS. The experts agreed that the subxiphoid UniVATS approach could reduce intercostal nerve injury and postoperative pain, but it was not recommended for complex lung surgeries.

Nonintubated UniVATS approach for lung cancer

For the sake of less invasive procedure, thoracic surgeons and anesthetists have tried to perform nonintubated thoracic surgeries. The earliest awake thoracoscopic lung surgery was reported in 2004 (75), and nonintubation was first combined with UniVATS in 2010 (76). It was reported in a series of 40 nonintubated UniVATS cases that the conversion rate was 7.5% to intubation and 2.5% to multi-portal VATS. The postoperative complication rate was 17.5%, which was higher than the reported rate of 3–6% in nonintubated multi-portal VATS (77). According to another cohort of 188 cases, the conversion rate was 1.6% to intubation and 2.7% to multi-portal approach, followed by a complication rate of 8.5% after surgery (78). In another study on lung biopsy in patients with interstitial lung diseases, the conversion to 2-portal rate was 7.0% due to extensive pleural adhesion (79). Current publications of safety and feasibility in nonintubated VATS, either uniportal or multi-portal, were mainly case reports and case series. The lack of prospective clinical trials and the high demand for anesthetic team had limited the development of nonintubated UniVATS (80). Multidisciplinary team should implement strict controls over contraindications, including inexperienced team, difficulty in airway management, obesity, persistent cough, previous surgery, coagulation disorder, and neurologic symptoms (81). Nonintubated UniVATS represented the thoracic surgeons’ constant pursuit of minimal invasion and revealed potentials for reducing costs as well as replacing some conventional surgeries by outpatient operations. Agreement was reached by the experts that nonintubated UniVATS could be applied in anatomical pulmonary resection on the condition of experienced medical team and rigorous selection of patients.

Conclusions

Above all, the consensus reported the definition and eligibility of UniVATS. The panel of experts also gave consentaneous opinions on some disputed questions based on present evidence. Compared with the consensus published by ESTS (8), this consensus reported similar results on most issues except the indication of UniVATS, extending from T2/N1 in the ESTS consensus to T3/N2 in this Chinese consensus, although the long-term outcomes should be evaluated by further studies. Moreover, this consensus presented some recommendations of surgical techniques from Chinese experts, and current literatures were reviewed concerning not only UniVATS lobectomy and segmentectomy, but also subxiphoid UniVATS approach and nonintubated UniVATS procedure. This consensus provided a blueprint for the current situation of UniVATS for lung cancer in China. There were also limitations in this consensus. Only 11 experts have performed lung cancer resection by subxiphoid UniVATS approach, the agreement on this issue was based on the voting result from the 11 experts. Another possible limitation was selection bias, all the experts with the same interests had already completed their learning curves, training surgeons should take this into account. Looking back in history, the development of minimally invasive thoracic surgery represented the surgeons’ constant pursuit of less trauma and faster recovery without compromising on efficacy. Such goals served as the driving force behind the evolution of relevant theories as well as science and technology. Theoretical innovation was reflected in the emerging types of minimally invasive surgery: subxiphoid UniVATS, tube-less UniVATS, even tube-less subxiphoid UniVATS (82), and natural orifice transluminal UniVATS (83). Meanwhile, scientific and technological evolution witnessed the emergence of new medical devices such as hybrid operating room, glasses-free 3D viewing system, fluorescence imaging endoscope, needle-like instruments, holographic projection, and uniportal robotic surgical system (84). From the survey, we known that over 90% of the experts in this consensus project agreed that the progress of UniVATS had benefited from the improvement of surgical instruments; 83% experts considered that UniVATS would be a promising direction of minimally invasive thoracic surgery. As 95% experts agreed on the demand for randomized controlled trials of UniVATS, prospective studies evaluating long-term outcomes should be conducted to verify the practical value of UniVATS in comparison with multi-portal VATS. The article’s supplementary files as
  83 in total

1.  Single- versus multiple-port thoracoscopic lobectomy for lung cancer: a propensity-matched study†.

Authors:  Yaxing Shen; Hao Wang; Mingxiang Feng; Yong Xi; Lijie Tan; Qun Wang
Journal:  Eur J Cardiothorac Surg       Date:  2015-10-13       Impact factor: 4.191

2.  Intra-pericardial double sleeve uniportal video-assisted thoracoscopic surgery left upper lobectomy.

Authors:  Firas Abu Akar; Chenlu Yang; Lei Lin; Shi Jia Min; Lei Jiang
Journal:  J Vis Surg       Date:  2017-04-10

3.  The technique of VATS right pneumonectomy.

Authors:  Fernando Vannucci; Arthur Vieira; Paula A Ugalde
Journal:  J Vis Surg       Date:  2018-01-15

4.  Awake single-access (uniportal) video-assisted thoracoscopic surgery for peripheral pulmonary nodules in a complete ambulatory setting.

Authors:  Gaetano Rocco; Vincenzo Romano; Rosanna Accardo; Alfonso Tempesta; Carmine La Manna; Antonello La Rocca; Nicola Martucci; Massimiliano D' Aiuto; Emilia Polimeno
Journal:  Ann Thorac Surg       Date:  2010-05       Impact factor: 4.330

5.  Video-assisted thoracoscopic surgery sleeve lobectomy with bronchoplasty: an improved operative technique.

Authors:  Yun Li; Jun Wang
Journal:  Eur J Cardiothorac Surg       Date:  2013-04-04       Impact factor: 4.191

6.  The Shanghai Pulmonary Hospital uniportal subxiphoid approach for lung segmentectomies.

Authors:  Giuseppe Aresu; Helen Weaver; Liang Wu; Lei Lin; Gening Jiang; Lei Jiang
Journal:  J Vis Surg       Date:  2016-12-02

7.  Single-port video-assisted thoracic surgery in 1063 cases: a single-institution experience†.

Authors:  Dong Xie; Haifeng Wang; Ke Fei; Chang Chen; Deping Zhao; Xiao Zhou; Boxiong Xie; Lei Jiang; Qiankun Chen; Nan Song; Jie Dai; Gening Jiang; Yuming Zhu
Journal:  Eur J Cardiothorac Surg       Date:  2016-01       Impact factor: 4.191

Review 8.  Non-intubated uniportal lung surgery†.

Authors:  Gaetano Rocco
Journal:  Eur J Cardiothorac Surg       Date:  2016-01       Impact factor: 4.191

9.  Transcervical uniportal pulmonary lobectomy.

Authors:  Marcin Zieliński; Tomasz Nabialek; Juliusz Pankowski
Journal:  J Vis Surg       Date:  2018-02-27

10.  Uniportal video-assisted thoracoscopic early learning curve for major lung resections in a high volume training center.

Authors:  Luis Angel Hernandez-Arenas; Lei Lin; Rushmi D Purmessur; Yiming Zhou; Gening Jiang; Yuming Zhu
Journal:  J Thorac Dis       Date:  2018-11       Impact factor: 2.895

View more
  4 in total

1.  Learning curve of uniportal video-assisted thoracoscopic lobectomy: an analysis of the proficiency of 538 cases from a single centre.

Authors:  Wen-Hao Li; Hua Cheng; Xiang-Feng Gan; Xiao-Jian Li; Xiao-Jin Wang; Xiang-Wen Wu; Hong-Cheng Zhong; Tian-Chi Wu; Wen-Wen Huo; Shao-Long Ju; Liang-Zhan Lv; Qing-Dong Cao
Journal:  Interact Cardiovasc Thorac Surg       Date:  2022-05-02

2.  Efficacy of multi-groove silicone drains in single-port video-assisted thoracoscopic lung cancer surgery and their effect on C-reactive protein: a single-center experience.

Authors:  Yuanshan Yao; Qingwang Hua; Suyue Liu; Zhenhua Yang; Haibo Shen; Wen Gao
Journal:  J Thorac Dis       Date:  2021-12       Impact factor: 3.005

3.  Electromagnetic Navigation Bronchoscopy Integrated Non-intubated Uniportal VATS in Localization and Resection of Pulmonary Nodules.

Authors:  Rui Wang; Yu Jiang; Jiaxi He; Yuechun Lin; Zhufeng Wang; Shuben Li
Journal:  Front Surg       Date:  2022-04-05

4.  Effect and feasibility of uniportal thoracoscopic surgery in the treatment of early-stage lung cancer in a primary hospital.

Authors:  Xiaoping Zuo; Guofeng Liu; Xiaochuan Liu; Yongjian Feng; Haijun Zhang
Journal:  Transl Cancer Res       Date:  2021-07       Impact factor: 1.241

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.